| Protein category: |
Recombinant protein |
| Source: |
proteins, Recombinants or rec |
| Target: |
BMDF / Bcl2 modifying factor Protein |
| Description: |
Complex subunit associated factors are involved in hybridoma growth, Eosinohils, NFKB 105 subunit for example is a polypetide gene enhancer of genes in B cells, eritroid proliferation and derived from promotor binding stimulating subunits on the DNA binding complex, transcription related growth factors and stimulating factors or repressing nuclear factors are complex subunits of proteins involved in cell differentiation, Aplha |
| Conjugation: |
histidine |
| Properties: |
Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine, , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp |
| Group: |
recombinants |
| Gene target: |
BMF / Bcl2 modifying factor Protein (His Tag) |
| Short name: |
Recombinant BMF / Bcl2 modifying factor Protein (His Tag) |
| Technique: |
E, Tags, adv advises they will be reconstituted in a buffer soluion or culture medium for cell culture, coli recombinant proteins are , supplied as white sterile powder lyopillized, Recombinant, genetic recombinations , in Escherichia coli |
| Label: |
His |
| Species: |
Humans, Human |
| Alternative name: |
sapiens Bcl2 modifying factor / B-cell CLL/lymphoma 2 modifying factor Protein (histidine detection labelled), recombinant H |
| Alternative technique: |
rec |
| Alternative to gene target: |
BMF and IDBG-6070 and ENSG00000104081 and 90427, BMF and IDBG-646206 and ENSBTAG00000012180 and 541141, Bmf and IDBG-198160 and ENSMUSG00000040093 and 171543, Plasma membranes, protein binding, this GO :0001669 and acrosomal vesicle and cellular component this GO :0005515 and protein binding and molecular function this GO :0005737 and cytoplasm and cellular component this GO :0005741 and mitochondrial outer membrane and cellular component this GO :0005829 and cytosol and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006915 and apoptotic process and biological process this GO :0015629 and actin cytoskeleton and cellular component this GO :0016459 and myosin complex and cellular component this GO :0032464 and positive regulation of protein homooli this GO merization and biological process this GO :0043276 and anoikis and biological process this GO :0090200 and positive regulation of release of cytochrome c from mitochondria and biological process this GO :0097193 and intrinsic apoptotic signaling pathway and biological process this GO :1900740 and positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway and biological process this GO :2001234 and negative regulation of apoptotic signaling pathway and biological process this GO :2001235 and positive regulation of apoptotic signaling pathway and biological process this GO :2001244 and positive regulation of intrinsic apoptotic signaling pathway and biological process, this GO :0005515 : protein binding, this GO :0005515 : protein binding, Bcl2 modifying factor |
| Identity: |
24132 |
| Gene: |
BMF |
More about : BMF |
| Long gene name: |
Bcl2 modifying factor |
| Synonyms: |
FLJ00065 |
| Locus: |
15q15, 1 |
| Discovery year: |
2004-01-16 |
| GenBank acession: |
BC060783 |
| Entrez gene record: |
90427 |
| Pubmed identfication: |
11546872 |
| RefSeq identity: |
NM_033503 |
| Classification: |
BCL2 homology region 3 (BH3) only |
| Havana BLAST/BLAT: |
OTTHUMG00000129875 |